ACTA1 and prostate cancer: For instance, α-SMA not only contributes to distinguishing CAFs with a myofibroblastic phenotype in several tumors (a remarkable exception is the downregulation of α-SMA in the prostate cancers matrix) but also acts as a common biomarker of stromal cells, including smooth muscle cells and vascular pericytes [24–26].